Body mass index and waist circumference in patients with established coronary artery disease over a 20-year period.
作者信息
Jankowski Piotr, Kozieł Paweł, Pająk Andrzej
机构信息
Department of Internal Medicine and Geriatric Cardiology, Center of Postgraduate Medical Education, Warsaw, Poland.
Department of Epidemiology and Health Promotion, School of Public Health, Center of Postgraduate Medical Education, Warsaw, Poland.
出版信息
Cardiol J. 2023;30(1):150-152. doi: 10.5603/CJ.a2023.0001. Epub 2023 Jan 18.
Abstract
摘要
相似文献
1
Body mass index and waist circumference in patients with established coronary artery disease over a 20-year period.20年间确诊冠心病患者的体重指数和腰围
Cardiol J. 2023;30(1):150-152. doi: 10.5603/CJ.a2023.0001. Epub 2023 Jan 18.
2
Correlation study on waist circumference-triglyceride (WT) index and coronary artery scores in patients with coronary heart disease.冠心病患者腰围-甘油三酯（WT）指数与冠状动脉评分的相关性研究
Eur Rev Med Pharmacol Sci. 2015 Jan;19(1):113-8.
3
Volumes of coronary plaque disease in relation to body mass index, waist circumference, truncal fat mass and epicardial adipose tissue in patients with type 2 diabetes mellitus and controls.2 型糖尿病患者及对照者中冠状动脉斑块疾病容积与体重指数、腰围、躯干脂肪量和心外膜脂肪组织的关系。
Diab Vasc Dis Res. 2019 Jul;16(4):328-336. doi: 10.1177/1479164119825761. Epub 2019 Feb 3.
4
The relationship of body composition indices with the significance, extension and severity of coronary artery disease.体成分指标与冠状动脉疾病的意义、程度和严重程度的关系。
Nutr Metab Cardiovasc Dis. 2020 Nov 27;30(12):2279-2285. doi: 10.1016/j.numecd.2020.07.014. Epub 2020 Jul 20.
5
Body mass index and waist/height ratio for prediction of severity of coronary artery disease.体重指数和腰高比用于预测冠状动脉疾病的严重程度。
BMC Res Notes. 2014 Apr 17;7:246. doi: 10.1186/1756-0500-7-246.
6
Obesity in patients with established coronary artery disease over a 20-year period (1997-2017).在过去 20 年期间（1997-2017 年）患有已确诊冠状动脉疾病的患者中的肥胖。
Pol Arch Intern Med. 2021 Jan 29;131(1):26-32. doi: 10.20452/pamw.15742. Epub 2021 Jan 8.
7
Serum endothelin-1 level positively correlates with waist and hip circumferences in stable coronary artery disease patients.血清内皮素-1 水平与稳定型冠状动脉疾病患者的腰围和臀围呈正相关。
Rev Cardiovasc Med. 2021 Sep 24;22(3):919-924. doi: 10.31083/j.rcm2203099.
8
Comparison of body mass index and waist/height ratio in predicting definite coronary artery disease.体重指数与腰高比在预测确诊冠状动脉疾病中的比较。
Ann Nutr Metab. 2008;53(3-4):162-6. doi: 10.1159/000172977. Epub 2008 Nov 14.
9
Waist circumference compared with other obesity parameters as determinants of coronary artery disease in essential hypertension: a 6-year follow-up study.在原发性高血压中，将腰围与其他肥胖参数作为冠状动脉疾病的决定因素进行比较：一项6年随访研究。
Hypertens Res. 2016 Jun;39(6):475-9. doi: 10.1038/hr.2016.8. Epub 2016 Feb 11.
10
Usefulness of hypertriglyceridemic waist phenotype in type 2 diabetes mellitus to predict the presence of coronary artery disease as assessed by computed tomographic coronary angiography.利用高三酰甘油腰围表型预测 2 型糖尿病患者冠状动脉疾病的存在，该预测方法通过计算机断层冠状动脉造影评估。
Am J Cardiol. 2010 Dec 15;106(12):1747-53. doi: 10.1016/j.amjcard.2010.08.015. Epub 2010 Oct 26.
引用本文的文献
1
SELECT semaglutide to improve outcomes in patients with obesity and cardiovascular disease, also without diabetes.选择司美格鲁肽以改善肥胖和心血管疾病患者（包括无糖尿病患者）的治疗效果。
Cardiol J. 2024;31(5):782-783. doi: 10.5603/cj.102158. Epub 2024 Sep 17.
本文引用的文献
1
Management and predictors of clinical events in 75 686 patients with acute myocardial infarction.75686例急性心肌梗死患者临床事件的管理与预测因素
Kardiol Pol. 2022;80(4):468-475. doi: 10.33963/KP.a2022.0058. Epub 2022 Feb 21.
2
Obesity in patients with established coronary artery disease over a 20-year period (1997-2017).在过去 20 年期间（1997-2017 年）患有已确诊冠状动脉疾病的患者中的肥胖。
Pol Arch Intern Med. 2021 Jan 29;131(1):26-32. doi: 10.20452/pamw.15742. Epub 2021 Jan 8.
3
Pharmacotherapy in patients with chronic coronary syndromes over a 20-year period (1997-2017).20年期间（1997 - 2017年）慢性冠状动脉综合征患者的药物治疗
Kardiol Pol. 2020 Nov 25;78(11):1156-1158. doi: 10.33963/KP.15591. Epub 2020 Sep 3.
4
Secondary prevention of coronary artery disease in Poland. Results from the POLASPIRE survey.波兰的冠心病二级预防。来自 POLASPIRE 调查的结果。
Cardiol J. 2020;27(5):533-540. doi: 10.5603/CJ.a2020.0072. Epub 2020 May 21.
5
Causal relationships between obesity and the leading causes of death in women and men.肥胖与女性和男性主要死因之间的因果关系。
PLoS Genet. 2019 Oct 24;15(10):e1008405. doi: 10.1371/journal.pgen.1008405. eCollection 2019 Oct.
6
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.2019年欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南
Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425.
7
Normal body mass index with central obesity has increased risk of coronary artery calcification in Korean patients with chronic kidney disease.韩国慢性肾脏病患者，即使身体质量指数正常但存在中心型肥胖，其冠状动脉钙化的风险也会增加。
Kidney Int. 2016 Dec;90(6):1368-1376. doi: 10.1016/j.kint.2016.09.011.
8
[Coordinated care after myocardial infarction. The statement of the Polish Cardiac Society and the Agency for Health Technology Assessment and Tariff System].[心肌梗死后的协调护理。波兰心脏病学会与卫生技术评估和收费系统机构的声明]
Kardiol Pol. 2016;74(8):800-11. doi: 10.5603/KP.2016.0118.
9
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲临床实践心血管疾病预防指南：欧洲心脏病学会和其他学会关于临床实践心血管疾病预防的第六联合工作组（由10个学会的代表和特邀专家组成）由欧洲心血管预防与康复协会（EACPR）特别贡献制定。
Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23.
10
Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity".将体重指数与中心性肥胖指标相结合评估冠心病患者死亡率：“正常体重中心性肥胖”的作用。
J Am Coll Cardiol. 2013 Feb 5;61(5):553-60. doi: 10.1016/j.jacc.2012.10.035.
Zotero 插件